{"id":"https://openalex.org/W1977804333","doi":"https://doi.org/10.1158/1538-7445.am2014-1319","title":"Abstract 1319: Vulnerability and resistance in glioblastoma to G2-specific drugs","display_name":"Abstract 1319: Vulnerability and resistance in glioblastoma to G2-specific drugs","publication_year":2014,"publication_date":"2014-10-01","ids":{"openalex":"https://openalex.org/W1977804333","doi":"https://doi.org/10.1158/1538-7445.am2014-1319","mag":"1977804333"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2014-1319","doi":"https://doi.org/10.1158/1538-7445.am2014-1319","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-1319","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031163794","display_name":"Harshil Dhruv","orcid":"https://orcid.org/0000-0003-2571-6649","observed_orcids":["https://orcid.org/0000-0003-2571-6649"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harshil D. Dhruv","raw_affiliation_strings":["1TGen, Phoenix, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1TGen, Phoenix, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew D. Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew D. Nelson","raw_affiliation_strings":["1TGen, Phoenix, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1TGen, Phoenix, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053877088","display_name":"Brock A. Armstrong","orcid":"https://orcid.org/0009-0008-4490-0824","observed_orcids":["https://orcid.org/0009-0008-4490-0824"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brock Armstrong","raw_affiliation_strings":["1TGen, Phoenix, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1TGen, Phoenix, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044158880","display_name":"Julie L. Boerner","orcid":"https://orcid.org/0000-0003-1711-4998","observed_orcids":["https://orcid.org/0000-0003-1711-4998"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie L. Boerner","raw_affiliation_strings":["2Wayne State University, Detroit, MI;","#N# 2Wayne State University, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Wayne State University, Detroit, MI;","institution_ids":["https://openalex.org/I185443292"]},{"raw_affiliation_string":"#N# 2Wayne State University, Detroit, MI","institution_ids":["https://openalex.org/I185443292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jann N. Sarkaria","raw_affiliation_strings":["3Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016790638","display_name":"Nhan L. Tran","orcid":"https://orcid.org/0000-0003-0908-9964","observed_orcids":["https://orcid.org/0000-0003-0908-9964"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nhan L. Tran","raw_affiliation_strings":["1TGen, Phoenix, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1TGen, Phoenix, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055952981","display_name":"Michael E. Berens","orcid":"https://orcid.org/0000-0002-3382-6787","observed_orcids":["https://orcid.org/0000-0002-3382-6787"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Berens","raw_affiliation_strings":["1TGen, Phoenix, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1TGen, Phoenix, AZ;","institution_ids":["https://openalex.org/I1284308235"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"19_Supplement","first_page":"1319","last_page":"1319"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9290000200271606},{"id":"https://openalex.org/keywords/wee1-kinase-inhibition","display_name":"WEE1 kinase inhibition","score":0.7889999747276306},{"id":"https://openalex.org/keywords/mk-1775","display_name":"MK-1775","score":0.9779999852180481},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/p53-loss","display_name":"p53 deficiency","score":0.824999988079071},{"id":"https://openalex.org/keywords/g2-checkpoint","display_name":"G2 checkpoint","score":0.9449999928474426},{"id":"https://openalex.org/keywords/g1-s-checkpoint","display_name":"G1/S checkpoint","score":0.7599999904632568},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6819999814033508},{"id":"https://openalex.org/keywords/combination-therapy-synergy","display_name":"combination therapy synergy","score":0.6600000262260437},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8650000095367432},{"id":"https://openalex.org/keywords/glioma-cell-lines","display_name":"glioma cell lines","score":0.8809999823570251},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.5960000157356262},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5720000267028809},{"id":"https://openalex.org/keywords/radiosensitization","display_name":"radiosensitization","score":0.5770000219345093},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.5519999861717224}],"concepts":[{"id":"https://openalex.org/C2781252693","wikidata":"https://www.wikidata.org/wiki/Q7979264","display_name":"Wee1","level":5,"score":0.8270837664604187},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.7557649612426758},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.652907133102417},{"id":"https://openalex.org/C105696609","wikidata":"https://www.wikidata.org/wiki/Q1068809","display_name":"Cell cycle checkpoint","level":4,"score":0.5930385589599609},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5863863825798035},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5336431264877319},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.47561508417129517},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.43140125274658203},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.4182218611240387},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.412395179271698},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3521841764450073},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3472954034805298},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3450787663459778},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3445797860622406},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3410349190235138},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2951319217681885},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15871989727020264},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.12485882639884949},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10595551133155823}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2014-1319","doi":"https://doi.org/10.1158/1538-7445.am2014-1319","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2014-1319","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2012014075","https://openalex.org/W2148636166","https://openalex.org/W2324243307","https://openalex.org/W1764369885","https://openalex.org/W4403509816","https://openalex.org/W2468740668","https://openalex.org/W2811278368","https://openalex.org/W2096293110","https://openalex.org/W2133613025","https://openalex.org/W2554016176"],"abstract_inverted_index":{"Abstract":[0],"Glioblastoma":[1],"multiforme":[2],"(GBM)":[3],"is":[4,108],"the":[5,27,35,73,100,117,224,305,321,360,365],"most":[6,9],"common":[7],"and":[8,95,102,111,137,160,172,178,188,201,220,233,298,349],"lethal":[10],"primary":[11],"malignant":[12],"brain":[13],"tumor,":[14],"affecting":[15],"25,000":[16],"patients":[17],"per":[18],"year.":[19],"Approximately":[20],"87%":[21],"of":[22,37,83,98,116,145,149,182,223,248,252,268,271,281,295,304,359,364],"GBMs":[23],"have":[24],"abnormalities":[25],"in":[26,78,126,132,135,138,189,211,283,351],"p53":[28,221,273,293],"pathway":[29],"that":[30,77,120,278,308],"affects":[31],"G2":[32,46,57,103],"checkpoint.":[33],"In":[34],"absence":[36],"p53,":[38],"Wee1":[39,51,84,118,313],"kinase":[40,119],"has":[41,121],"been":[42],"shown":[43],"to":[44,88,93,199,353],"regulate":[45],"checkpoint":[47,176],"upon":[48],"chemotherapeutic":[49,130],"insult.":[50],"inhibits":[52],"CDC2":[53],"function,":[54],"thereby":[55],"promoting":[56],"phase":[58],"cell":[59,165,209,225,256],"cycle":[60],"arrest,":[61],"thus":[62],"preventing":[63],"damaged":[64],"cells":[65,297],"from":[66],"entering":[67],"into":[68],"premature":[69],"mitosis":[70],"without":[71],"repairing":[72],"DNA.":[74],"We":[75],"hypothesize":[76],"p53-deficient":[79],"tumor":[80],"cells,":[81],"inhibitors":[82],"would":[85],"be":[86],"effective":[87],"heighten":[89],"DNA":[90,316],"damage":[91,317],"due":[92],"genetic":[94],"pharmacologic":[96],"loss":[97],"both":[99],"G1":[101,175],"checkpoints,":[104],"respectively.":[105],"MK-1775":[106,183,200,232,282],"(Merck)":[107],"a":[109,185,236,300],"potent":[110],"selective":[112],"small":[113],"molecule":[114],"inhibitor":[115],"demonstrated":[122,196,277],"enhanced":[123],"cytotoxic":[124,180],"effect":[125,238,262,265],"combination":[127,190,245,284],"with":[128,170,191,231,244,266,285],"several":[129],"agents":[131,205],"preclinical":[133],"studies":[134],"vitro":[136],"vivo.":[139],"Here,":[140],"we":[141],"selected":[142],"an":[143,260],"array":[144],"short":[146],"term":[147,162],"cultures":[148],"glioma":[150,164,208,255,296],"patient":[151],"derived":[152],"xenograft":[153],"(PDX)":[154],"models":[155],"(GBM12,":[156],"GBM43,":[157,243],"GBM79,":[158],"GBM84)":[159],"long":[161],"established":[163],"lines":[166,210,226,257],"(U87,":[167],"SF767,":[168],"T98G)":[169],"aberrant":[171],"wild":[173],"type":[174],"pathways":[177],"investigated":[179],"effects":[181,280],"as":[184,203],"single":[186,204],"agent":[187],"Temozolomide":[192],"(TMZ).":[193],"Our":[194,275],"results":[195,276],"differential":[197],"sensitivity":[198,219],"TMZ":[202,218,234],"for":[206,239,314,368],"different":[207],"vitro.":[212],"However,":[213],"no":[214],"correlation":[215],"between":[216],"MK-1775,":[217],"status":[222,294],"was":[227],"observed.":[228],"Combination":[229,250],"therapy":[230,251],"showed":[235,259],"synergistic":[237,279],"one":[240],"PDX":[241],"model,":[242],"index":[246],"(CI)":[247],"0.4.":[249],"all":[253],"other":[254],"either":[258],"additive":[261],"or":[263],"antagonistic":[264],"CI":[267],">0.75":[269],"irrespective":[270],"their":[272],"status.":[274],"chemotherapy":[286],"(TMZ)":[287],"are":[288],"not":[289],"solely":[290],"dependent":[291],"on":[292,312],"require":[299],"more":[301],"comprehensivce":[302],"understanding":[303],"molecular":[306],"mechanism":[307],"dictates":[309],"GBM's":[310],"dependence":[311],"escaping":[315],"therapy.":[318],"Supported":[319],"by":[320],"Ben":[322],"&":[323],"Catherine":[324],"Ivy":[325],"Foundation":[326],"Citation":[327],"Format:":[328],"Harshil":[329],"D.":[330,333],"Dhruv,":[331],"Andrew":[332],"Nelson,":[334],"Brock":[335],"Armstrong,":[336],"Julie":[337],"L.":[338,344],"Boerner,":[339],"Jann":[340],"N.":[341],"Sarkaria,":[342],"Nhan":[343],"Tran,":[345],"Michael":[346],"Berens.":[347],"Vulnerability":[348],"resistance":[350],"glioblastoma":[352],"G2-specific":[354],"drugs.":[355],"[abstract].":[356],"In:":[357],"Proceedings":[358],"105th":[361],"Annual":[362],"Meeting":[363],"American":[366],"Association":[367],"Cancer":[369,380],"Research;":[370],"2014":[371],"Apr":[372],"5-9;":[373],"San":[374],"Diego,":[375],"CA.":[376],"Philadelphia":[377],"(PA):":[378],"AACR;":[379],"Res":[381],"2014;74(19":[382],"Suppl):Abstract":[383],"nr":[384],"1319.":[385],"doi:10.1158/1538-7445.AM2014-1319":[386]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}